Showing results (91-100 of 105) with videos related to
Sort By:
Pageof 11
Journal of Pediatric Gastroenterology and Nutrition|May 20, 2011
Do children with IBD really respond better than adults to thiopurines?J R Goodhand, N Tshuma, A Rao, et al.Journal of Applied Microbiology|February 16, 2006
Molecular characterization of the bacteria adherent to human colorectal mucosaG L Green, J Brostoff, B Hudspith, et al.Gut|February 1, 1994
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivoG R Davies, N J Simmonds, T R Stevens, et al.Gut|September 1, 1996
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitisA D Millar, D S Rampton, C L Chander, et al.Gut|September 11, 2009
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel diseaseL Rovedatti, T Kudo, P Biancheri, et al.Clinical Nephrology|March 1, 1984
Treatment of chronic renal failure with dietary fiberD S Rampton, S L Cohen, V D Crammond, et al.Alimentary Pharmacology & Therapeutics|March 13, 2012
The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descentJ R Goodhand, N Kamperidis, N M Joshi, et al.Annals of Human Genetics|August 14, 2003
The causal element for the lactase persistence/non-persistence polymorphism is located in a 1 Mb region of linkage disequilibrium in EuropeansM Poulter, E Hollox, C B Harvey, et al.Rheumatology (Oxford, England)|February 7, 2001
Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn's disease and ankylosing spondylitisH Tiwana, R S Natt, R Benitez-Brito, et al.Human Molecular Genetics|April 1, 1995
The lactase persistence/non-persistence polymorphism is controlled by a cis-acting elementY Wang, C B Harvey, W S Pratt, et al.Pageof 11